Xiaoyang Qi

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Harold W. Davis · 3 shared papers, 2020–2025 · strength 0.52
   • Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
   • Paper Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual … DOI 10.4251/wjgo.v13.i6.550↗
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
2. Ahmet Kaynak · 2 shared papers, 2021–2025 · strength 0.41
   • Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
   • Paper Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual … DOI 10.4251/wjgo.v13.i6.550↗
3. Vladimir Y. Bogdanov · 4 shared papers, 2014–2025 · strength 0.41
   • Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
4. Clayton S. Lewis · 3 shared papers, 2016–2025 · strength 0.37
   • Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
5. Zhengtao Chu · 5 shared papers, 2013–2020 · strength 0.30
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. DOI 10.1016/j.tranon.2015.03.011↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
6. Syed Ameen Ahmad · 4 shared papers, 2013–2020 · strength 0.23
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
   • Paper Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer. DOI 10.1371/journal.pone.0075507↗
7. Petr Müller · 1 shared paper, 2025 · strength 0.22
   • Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
8. Olugbenga Olanrele Olowokure · 2 shared papers, 2014–2020 · strength 0.19
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
   • Paper Pancreatic cancer: current standards, working towards a new therapeutic approach. DOI 10.1586/14737140.2014.895937↗
9. Kombo F. N’Guessan · 1 shared paper, 2020 · strength 0.11
   • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
10. Jen Jen Yeh · 1 shared paper, 2020 · strength 0.11
    • Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
11. Dusten J. Unruh · 2 shared papers, 2014–2016 · strength 0.08
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
    • Paper Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal aden… DOI 10.1002/ijc.28327↗
12. Victor Blanco · 1 shared paper, 2015 · strength 0.07
    • Paper Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. DOI 10.1016/j.tranon.2015.03.011↗
13. Nigel Mackman · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
14. Alisa S. Wolberg · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
15. Georg F. Weber · 1 shared paper, 2016 · strength 0.05
    • Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
16. Holger Kalthoff · 1 shared paper, 2014 · strength 0.03
    • Paper Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal aden… DOI 10.1002/ijc.28327↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.